40
Participants
Start Date
February 15, 2025
Primary Completion Date
May 5, 2025
Study Completion Date
May 5, 2025
HFrEF Polypill
"The heart failure with reduced ejection fraction (HFrEF) polypill will include 4 guideline recommended medications used to treat HFrEF patients. The dose of initiation and titration will be at the investigator's discretion.~HFrEF polypill strength 1: bisoprolol 2.5 mg + losartan 25 mg + eplerenone 25 mg + dapagliflozin 10 mg; HFrEF polypill strength 2: bisoprolol 5 mg + losartan 50 mg + eplerenone 25 mg + dapagliflozin 10 mg; HFrEF polypill strength 3: bisoprolol 10 mg + losartan 100 + eplerenone 50 mg + dapagliflozin 10 mg"
Comparator Arm
Participants in the comparator control group will receive usual care by their healthcare providers. Providers will be encouraged to treat all participants according to international and local clinical practice guidelines.
Colombo South Teaching Hospital, Colombo
National Hospital of Sri Lanka, Colombo
The George Institute
OTHER
RemediumOne
UNKNOWN
Centre for Chronic Disease Control, India
OTHER
Washington University School of Medicine
OTHER